Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Understanding SARS-CoV-2's spread and immune response is key to developing treatments and vaccines, but preventive measures remain important.

Age, health conditions, race, and gender affect COVID-19 risk.

Testosterone's effects on COVID-19 are unclear and need more research.

Ivermectin effectively treats hair loss syndrome in black-tailed deer.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

Isolated rheumatic tricuspid valve disease is very rare.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

COVID-19 affects multiple body systems, not just the lungs.

Understanding gender differences in COVID-19 is crucial for effective health strategies.

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

High doses of albendazole can be deadly for alpacas.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.

Long COVID has severely affected a couple's health, finances, and social life.

Timely diagnosis of SLE is crucial due to symptom overlap with fibromyalgia.

A patient with Myotonic dystrophy type 1 had multiple tongue hemangiomas and was sensitive to anesthesia.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

COVID-19 can worsen upper gastrointestinal bleeding, requiring quick and varied treatments.

COVID-19 severely affects older adults with chronic heart, lung, or metabolic diseases.

Cholesterol affects coronavirus spread and could be a target for treatment.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Testosterone may influence COVID-19 severity and outcomes.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

The study identified five types of long COVID symptoms and suggests tailored management strategies for each.